Fundz

Neurolief Appoints Experienced Finance Executive as Chief Financial Officer

PRIVATEMar 14, 2023

Company

Neurolief

TampaBiotechnologyHealth CareMedicalMedical Equipment Manufacturing

Description

Neurolief, a medical neurotechnology innovator, announces the appointment of Anthony Borowicz as Chief Financial Officer.

Quick answer

Neurolief Appoints Experienced Finance Executive as Chief Financial Officer (March 14, 2023). Neurolief is based in Tampa, Florida, United States.

What did Neurolief announce on March 14, 2023?
Neurolief, a medical neurotechnology innovator, announces the appointment of Anthony Borowicz as Chief Financial Officer.
What does Neurolief do?
Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression.
Where is Neurolief based?
Neurolief is based in Tampa, Florida, United States.
Which similar companies made leadership changes around the same time?
GT Medical Technologies (March 16, 2023), Prolira (March 9, 2023), Ascidian Therapeutics (March 20, 2023) and OsteoCentric (March 8, 2023) also announced leadership changes within 45 days of Neurolief.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Medical Equipment Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Neurolief, and when

A new leader at Neurolief brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Neurolief raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neurolief, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neurolief. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neurolief

Location

Tampa, Florida, United States

About

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. The company’s devices either complement or provide an alternative to pharmaceutical therapies, which are often ineffective and are associated with potential short- and long-term adverse effects. Neurolief’s products are groundbreaking electronic head mounted devices designed to concurrently target major neural pathways in the head and thereby affect brain regions that are involved in control and modulation of pain and mood. These devices are intended to provide a highly effective, side-effects free treatment for the hundreds of millions of patients worldwide. Neurolief is led by a seasoned team with extensive experience and successful track record developing multiple neuromodulation devices for patients with central nervous system deficiencies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neurolief changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neurolief's next move

Learn about Strategic plan

Neurolief changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.